Psychotherapeutic Benefits of Opioid Agonist Therapy
- 12 June 2008
- journal article
- research article
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 27 (3) , 49-65
Abstract
Opioids have been used for centuries to treat a variety of psychiatric conditions with much success. The so-called “opium cure” lost popularity in the early 1950s with the development of non-addictive tricyclic antidepressants and monoamine oxidase inhibitors. Nonetheless, recent literature supports the potent role of methadone, buprenorphine, tramadol, morphine, and other opioids as effective, durable, and rapid therapeutic agents for anxiety and depression. This article reviews the medical literature on the treatment of psychiatric disorders with opioids (notably, methadone and buprenorphine) in both the non-opioid-dependent population and in the opioid-dependent methadone maintenance population. The most recent neurotransmitter theories on the origin of depression and anxiety will be reviewed, including current information on the role of serotonin, N-Methyl d-Aspartate, glutamate, cortisol, catecholamine, and dopamine in psychiatric disorders. The observation that methadone maintenance patients with co-existing psychiatric morbidity (so called dual diagnosis patients) require substantially higher methadone dosages by between 20% and 50% will be explored and qualified. The role of methadone and other opioids as beneficial psychiatric medications that are independent of their drug abuse mitigating properties will be discussed. The mechanisms by which methadone and other opioids can favorably modulate the neurotransmitter systems controlling mood will also be discussed.Keywords
This publication has 68 references indexed in Scilit:
- Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in IsraelDrug and Alcohol Dependence, 2006
- Determining Effective Methadone Doses for Individual Opioid-Dependent PatientsPLOS Medicine, 2006
- Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependenceEuropean Psychiatry, 2004
- Glutamate and DepressionAnnals of the New York Academy of Sciences, 2003
- Effective Medical Treatment of Opiate AddictionJAMA, 1998
- Psychiatric Comorbidity in Methadone Maintained PatientsJournal of Addictive Diseases, 1998
- The d- and l- isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cordNeuroscience Letters, 1997
- Buprenorphine Treatment of Refractory DepressionJournal of Clinical Psychopharmacology, 1995
- THE EFFECT OF CODEINE ON INVOLUTIONAL AND SENILE DEPRESSIONAnnals of the New York Academy of Sciences, 1982
- Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depressionMedical Hypotheses, 1981